Hologic Board Member, Sally W. Crawford, Recognized As NACD Directorship 100™ Honoree
May 17 2022 - 8:15AM
Business Wire
--The 16th Annual List Recognizes the Most
Influential Corporate Directors and Governance Experts--
Hologic, Inc. (Nasdaq: HOLX), a global leader in women’s health,
announced today that Board of Director's member, Sally W. Crawford,
has been recognized by the National Association of Corporate
Directors (NACD) as part of its 2022 NACD Directorship 100™ —
honoring the most influential peer-nominated leaders in the
boardroom and corporate governance community.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20220517005060/en/
Sally Crawford, Independent Lead Director
(Photo: Business Wire)
“Sally is truly deserving of this honor and her invaluable
leadership, dedication and expertise continue to contribute
significantly to Hologic and our purpose – to enable healthier
lives everywhere, every day,” said Steve MacMillan, Hologic’s
chairman, president and CEO. “We are extremely grateful for her
insightful and trusted guidance as Lead Independent Director, chair
of our Nominating and Corporate Governance Committee and a member
of our Compensation Committee.”
Now in its 16th year, the NACD Directorship 100 awards recognize
peer-nominated leading directors and governance professionals.
Honorees are evaluated in four key categories: integrity, mature
confidence, informed judgment, and high performance standards. A
selection committee reviews the nominees’ histories of advancing
board performance and leading corporate governance practices in
accordance with established NACD principles. The principles are a
framework that encourages excellence in areas that include risk
oversight, corporate strategy, compensation, and transparency.
“The NACD Directorship 100 continues to honor those who have
demonstrated exemplary board leadership and innovation in corporate
governance,” said Peter R. Gleason, NACD president and CEO. “We
honor these individuals’ forward-thinking minds and their ability
to lead their board and organizations to current and future
success.”
The complete list of the 2022 NACD Directorship 100 is available
at https://directorship100.nacdonline.org/honorees/2022.
About Hologic, Inc.
Hologic, Inc. is an innovative medical technology company
primarily focused on improving women’s health and well-being
through early detection and treatment. For more information on
Hologic, visit www.hologic.com.
About NACD
For more than 40 years, NACD has been on the leading edge of
corporate governance, setting standards of excellence that have
elevated board performance. NACD arms today’s directors with
insights and education that drive their mission forward, while
preparing a new generation of boardroom leaders to meet tomorrow’s
biggest challenges. NACD is a community of more than 23,000
directors driven by a common purpose: to be trusted catalysts of
economic opportunity and positive change—in businesses and in the
communities they serve. To learn more about NACD, visit
nacdonline.org.
SOURCE: Hologic, Inc.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220517005060/en/
Hologic Jane Mazur Vice President,
Corporate Communications 508.263.8764 (direct) 585.355.5978
(mobile) jane.mazur@hologic.com
Ryan Simon Vice President, Investor Relations 858.410.8514
ryan.simon@hologic.com
NACD Shannon Bernauer
sbernauer@nacdonline.org (571) 367-3688
Hologic (NASDAQ:HOLX)
Historical Stock Chart
From Aug 2024 to Sep 2024
Hologic (NASDAQ:HOLX)
Historical Stock Chart
From Sep 2023 to Sep 2024